ASCO Quality Care Symposium 2021

Adult Participation in Cancer Trials Higher Than Previously Thought

Enrollment rates varied widely by study type and institution.

Changes in Patient-Reported Outcomes Predict Response, Survival in Gastrointestinal Cancers

Treatment response, progression-free survival, and overall survival were all associated with patient-reported outcomes.

Breast Cancer Patients Who Are Not Represented in Clinical Trials Have an Increased Risk of Death

The unrepresented patient population had a significantly increased risk of death at 5 years.

Predicting End of Life for Patients With Metastatic Breast Cancer

Several factors were associated with 30-day mortality.

PSA Screening Recommendation Tied to Decrease in Prostate Cancer-Specific Survival

The 3-year prostate cancer-specific survival decreased significantly for insured patients.

Causes, Strategies for Managing ED Visits by Patients With Solid Malignancies

A retrospective review identified the underlying cause for cancer patients’ emergency department visits.

Real-World Data Support Same-Day Pegfilgrastim Prophylaxis to Reduce Febrile Neutropenia Risk

Investigators sought to determine if same-day administration of prophylactic pegfilgrastim was as effective as next-day administration.

EHR Screening Reveals Financial Toxicity in Most Patients With Breast Cancer

Systematic screening of patients’ electronic health record helped identify those patients at risk of financial toxicity.

Financial Burden Increasing for Privately Insured Cancer Patients

There was a significant increase in out-of-pocket costs for all 4 cancer types studied.